Design and rationale of the COMPLETE trial: A randomized, comparative effectiveness study of complete versus culprit-only percutaneous coronary intervention to treat multivessel coronary artery disease in patients presenting with ST-segment elevation myocardial infarction

This publication has 22 references indexed in Scilit:

• Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
  New England Journal of Medicine, 2015
• Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI and Multivessel Disease
  JACC, 2015
• Extent, Location, and Clinical Significance of Non–Infarct-Related Coronary Artery Disease Among Patients With ST-Elevation Myocardial Infarction
  JAMA, 2014
• Complete vs culprit-only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A systematic review and meta-analysis
  American Heart Journal, 2014
• Randomized Trial of Preventive Angioplasty in Myocardial Infarction
  New England Journal of Medicine, 2013
• Treatment of non-culprit lesions detected during primary PCI: long-term follow-up of a randomised clinical trial
  Netherlands Heart Journal, 2012
• A Prospective Natural-History Study of Coronary Atherosclerosis
  New England Journal of Medicine, 2011
• A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up
  Heart, 2009
• Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
  New England Journal of Medicine, 2009
• Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat™ for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study
  International Journal of Cardiovascular Interventions, 2004